Hostname: page-component-7479d7b7d-fwgfc Total loading time: 0 Render date: 2024-07-12T12:59:56.964Z Has data issue: false hasContentIssue false
  • English
  • Français

What ePROs are telling us about patients with substance use disorder

Published online by Cambridge University Press:  01 September 2022

S. Krasteva ,
Z. Apostolov  and
H. Kozhuharov
S. Krasteva*
Affiliation:
Medical University of Varna, Department Of Psychiatry And Medical Psychology, Varna, Bulgaria
Z. Apostolov
Affiliation:
Medical University of Varna, Department Of Psychiatry And Medical Psychology, Varna, Bulgaria
H. Kozhuharov
Affiliation:
Medical University of Varna, Department Of Psychiatry And Medical Psychology, Varna, Bulgaria
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Despite the high prevalence of substance use disorders, the majority of affected individuals do not seek any medical help or receive treatment targetting mainly symptoms of intoxication, withdrawal or general medical conditions due to chronic use of psychoactive substances. Patients with substance use disorders are more likely to remain undiagnosed regarding other psychiatric illnesses. Electronic patient-reported outcomes (ePRO) provide an easy-to-use instrument for detailed assessment at low economic cost.

Objectives

To assess patients’ attitude towards self-reporting of symptoms related to substance use, mood, anxiety, quality of sleep, medication intake, social performance, and psychotic symptoms.

Methods

Mobile application consisting of seven questionnaires (Mood, Anxiety, Substance Use, Sleep, Medication, Social Activity and Various symptoms) was offered for use to patients with substance use disorder. Enrolled subjects were encouraged to use the app to report their actual condition in accordance with their own willingness and lifestyle.

Results

Throughout the study a total of 1077 completed questionnaires were submitted, of which 193 (17.9%) were on mood, 188 (17.5%) - on substance use, 187 (17.4%) – on sleep, 155 (14.4%) – on anxiety, 139 (12.9%) – on medication intake, 111 (10.3%) – on psychotic symptoms, and 104 (9.7%) – on social performance.

Conclusions

Our research revealed that patients with substance use disorder are likely to share concerns regarding variety of psychiatric symptoms besides these attributed to their primary diagnosis. Implementation of ePROs can be a valuable tool for in-depth assessment and subsequent meeting the needs of such patients.

Disclosure

No significant relationships.

Keywords

electronic patient-reported outcomesdigital psychiatrysubstance use disorder
Type
Abstract
Information
European Psychiatry , Volume 65 , Special Issue S1: Abstracts of the 30th European Congress of Psychiatry , June 2022 , pp. S166
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.